Previous Section Index Home Page

26 July 2007 : Column 1364W—continued


Smoking: Public Expenditure

Sandra Gidley: To ask the Secretary of State for Health what measures his Department has put in place to monitor the spending by local authorities of money allocated by his Department to enforce the smoking ban. [153629]

Dawn Primarolo: I refer the hon. Member to the answer given on 17 April 2007, Official Report, column 590W.


26 July 2007 : Column 1365W

Surgery

Mr. Lansley: To ask the Secretary of State for Health how many (a) in-patient and (b) day case procedures were carried out (i) in England and (ii) in each strategic health authority area (A) for both elective and non-elective procedures and (B) for elective procedures only in each year since 1997-98; and what percentage of day cases each category represented of the total case procedures delivered in each strategic health authority area in the latest year for which figures are available. [149486]

Mr. Bradshaw: Information has been placed in the Library.

Vaccination: Aluminium

Tim Loughton: To ask the Secretary of State for Health (1) what levels of aluminium are contained in
26 July 2007 : Column 1366W
each vaccine provided to children; and if he will make a statement; [152765]

(2) what assessment he has made of the safe levels of aluminium in vaccines routinely provided to (a) babies and (b) children. [152766]

Dawn Primarolo: Aluminium salts are an essential ingredient of some vaccines in enhancing the protection offered by the vaccine. The safety record of aluminium in vaccines has been demonstrated over more than 50 years of use. There are no serious health risks associated with the small quantities of aluminium in some vaccines. As with many vaccine ingredients, aluminium can cause localised reactions such as redness, swelling and/or tenderness at the injection site.

The information on levels of aluminium in childhood vaccines is in the following table.

Childhood vaccines aluminium content
Aluminium content
PL number Vaccine ( d isease) Formulation SPC (2)* Label

00011/0245

Meningitec Vial (Meningitis C)

Aluminium phosphate 0.5mg per 0.5ml

0.125mg A1(3+)

Aluminium phosphate 0.125mg A1(3+)

00116/0351

Neisvac-C (Meningitis C)

Aluminium hydroxide 0.5mg per 0.5ml

Aluminium hydroxide hydrated 0.5mg A1(3+)

Aluminium hydroxide hydrated 0.5mg A1(3+)

06745/0076

M-M-R II vaccine injection (Measles, Mumps and Rubella)

None present

n/a

n/a

06745/0120

Pediacel injection (Diphtheria, tetanus, pertussis, polio and haemophilius influenzae type b (Hib))

Aluminium phosphate 1.5mg per 0.5ml

0.33±0.05mg A1(3+) calculated

Aluminium phosphate

06745/0121

Repevax injection (Diphtheria, tetanus, pertussis, polio)

Aluminium phosphate 0.33mg per 0.5ml

0.33mg

Aluminium phosphate 0.33mg

06745/0122

Repevax injection (Diphtheria, tetanus, pertussis, polio)

Aluminium phosphate 0.33mg per 0.5ml

0.33mg

Not legible

06745/0123

Revaxis injection (Tetanus, diphtheria, polio)

Aluminium hydroxide 0.35mg per 0.5ml

Aluminium hydroxide 0.35mg

Not legible

10592/0110

Priorix vaccine injection (Measles, Mumps and Rubella)

None present

n/a

n/a

10592/0209

Infanrix IPV vaccine injection (Diphtheria, tetanus, pertussis, polio)

Aluminium oxide hydrated 0.5mg

0.5mg

Aluminium hydroxide

10592/0216

Infanrix-IPV-Hib vaccine (Diphtheria, tetanus, pertussis, polio, haemophilius influenzae type b (Hib))

Aluminium hydroxide 0.5mg per 0.5ml

Aluminium hydroxide hydrated 0.5mg A1(3+)

Aluminium hydroxide

10592/0217

Menitorix (Haemophilius influenzae type b (Hib/(Meningitis C))

None present

n/a

n/a

13767/0013-14

Menjugate vaccine injection and aluminium hydroxide solvent (Meningitis C)

Aluminium hydroxide 1mg per 0.5ml

Not on sentinel aluminium hydroxide 0.3 to 0.4mg A1(3+)

Not on sentinel

EU/1/../167/...

Prevenar (Pneumococcal)

Aluminium phosphate 0.5mg per 0.5ml

Aluminium phosphate 0.5mg

Aluminium phosphate 0.5mg

Source:
Taken from electronic Medicines Compendium (eMC)

26 July 2007 : Column 1367W

Vaccination: Children

Tim Loughton: To ask the Secretary of State for Health if he will list the vaccines routinely given to (a) babies and (b) children. [152767]


26 July 2007 : Column 1368W

Dawn Primarolo: The information required is in the following table.

Immunisation schedule
Age What is given How it is given

2 months old

Diphtheria, tetanus, pertussis (whooping cough), polio and Haemophilus influenzae type b (Hib) (DTaP/IPV/Hib)

One injection

Pneumococcal infection (Pneumococcal conjugate vaccine, PCV)

One injection

3 months old

Diphtheria, tetanus, pertussis, polio and Haemophilus influenzae type b (Hib) (DTaP/IPV/Hib)

One injection

Meningitis C (meningococcal group C) (MenC)

One injection

4 months old

Diphtheria, tetanus, pertussis, polio and Haemophilus influenzas type b (Hib) (DTaP/IPV/Hib)

One injection

Meningitis C (meningococcal group C) (MenC)

One injection

Pneumococcal infection (Pneumococcal conjugate vaccine, PCV)

One injection

Around 12 months old

Haemophilus influenza type b (Hib) and meningitis C (Hib/MenC)

One injection

Around 13 months old

Measles, mumps and rubella (German measles) (MMR)

One injection

Pneumococcal infection (PCV)

One injection

3 years and 4 months to 5-years-old

Diphtheria, tetanus, pertussis (whooping cough) and polio (dTaP/IPV or DTaP/IPV)

One injection

Measles, mumps and rubella (MMR)

One injection

13 to 18-years-old

Diphtheria, tetanus, polio (Td/IPV)

One injection


York Hospitals NHS Trust

Hugh Bayley: To ask the Secretary of State for Health pursuant to the answer of 13 December 2006, Official Report, column 1189W, on York Hospitals NHS Trust, how many finished consultant episodes there were in each specialty at York Hospitals NHS Trust in 2005-06; and if he will make a statement. [151618]

Mr. Bradshaw: The requested information is set out in the following table.

Count of Finished Consultant Episodes by Main Specialty for provider code RCB ‘York Hospitals NHS Trust’ for 2005-06
Main specialty Main specialty description FCEs

100

General Surgery

9,512

101

Urology

6,244

110

Trauma and Orthopaedics

5,371

120

Ear, Nose and Throat (ENT)

2,181

130

Ophthalmology

3,509

140

Oral Surgery

1,574

180

Accident and Emergency

1,693

190

Anaesthetics

2,018

300

General Medicine

20,389

303

Clinical Haematology

1,206

330

Dermatology

26

370

Medical Oncology

225

400

Neurology

468

410

Rheumatology

568

420

Paediatrics

4,835

430

Geriatric Medicine

9,193

502

Gynaecology

9,199

560

Midwife episode

2,998

810

Radiology

*

822

Chemical Pathology

376

Notes:
1. Finished Consultant Episode (FCE)
An FCE is defined as a period of admitted patient care under one consultant within one healthcare provider. The figures do not represent the number of patients, as a person may have more than one episode of care within the year.
2. Main Specialty
The main specialty refers to the specialty under which the consultant is contracted.
3. Specialty
Care is needed when analysing Hospital Episode Statistics (HES) data by specialty, or by groups of specialties (such as acute). Trusts have different ways of managing specialties and attributing codes so it is better to analyse by specific diagnoses, operations or other recorded information.
4. Low Numbers
Due to reasons of confidentiality, figures between 1 and 5 have been suppressed and replaced with ‘*’(an asterisk).
5. Data Quality
HES are compiled from data sent by over 300 national health service trusts and primary care trusts in England. The Information Centre for health and social care liaises closely with these organisations to encourage submission of complete and valid data and seeks to minimise inaccuracies and the effect of missing and invalid data via HES processes. While this brings about improvement over time, some shortcomings remain.
6. Ungrossed Data
Figures have not been adjusted for shortfalls in data (ie the data are ungrossed).
Source: HES, The Information Centre for Health and Social Care.

Hugh Bayley: To ask the Secretary of State for Health what the (a) average and (b) maximum waiting time for (i) in-patient and (ii) day case admissions was at York Hospitals NHS Trust for the quarters ending (1) December 2006, (2) March 2007 and (3) June 2007. [151619]


26 July 2007 : Column 1369W

Mr. Bradshaw: The requested information is show in the following table.

Day case/inpatient Median wait Maximum wait

December 2006

Day case

8.5 weeks

25 to <26 weeks

December 2006

Inpatient

7.8 weeks

25 to <26 weeks

March 2007

Day case

6.7 weeks

19 to <20 weeks

March 2007

Inpatient

6.5 weeks

19 to <20 weeks

Source: Department of Health, NHS Finance, Performance and Operations.

Next Section Index Home Page